v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2022
Mar. 31, 2022
Current assets    
Cash $ 14,921,775 $ 17,072,419
Accounts receivable 114,849 127,965
Prepaid expenses and other current assets 857,287 956,623
Total current assets 15,893,911 18,157,007
Property and equipment, net 451,894 441,238
Right-of-use lease asset 663,539 696,698
Patents, net 2,063 2,200
Restricted cash 87,506 87,506
Deposits 33,305 33,305
Total assets 17,132,218 19,417,954
Current liabilities    
Accounts payable 439,745 499,962
Due to related parties 162,045 155,742
Deferred revenue 459,396 344,547
Lease liability, current portion 136,730 126,905
Other current liabilities 446,783 696,893
Total current liabilities 1,644,699 1,824,049
Lease liability, less current portion 567,321 602,505
Total liabilities 2,212,020 2,426,554
Stockholders’ Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 15,993,723 and 15,419,163 shares issued and outstanding as of June 30, 2022 and March 31, 2022, respectively 15,996 15,421
Additional paid-in capital 148,281,172 147,446,868
Accumulated deficit (133,234,849) (130,329,181)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests 15,062,319 17,133,108
Noncontrolling interests (142,121) (141,708)
Total stockholders’ equity 14,920,198 16,991,400
Total liabilities and stockholders’ equity $ 17,132,218 $ 19,417,954

Source